bindarit has been researched along with Atheroma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Liu, F; Liu, J; Peng, C; Tang, Y; Xiang, T; Yin, L; Yuan, Y; Zhou, X | 1 |
| Lai, Q; Li, W; Lou, J; Peng, C; Teng, Z; Xu, C; Yin, L; Zhang, C; Zhou, X | 1 |
2 other study(ies) available for bindarit and Atheroma
| Article | Year |
|---|---|
Biomimetic oral targeted delivery of bindarit for immunotherapy of atherosclerosis.
Topics: Administration, Oral; Animals; Biocompatible Materials; Biomimetics; Carbocyanines; Cells, Cultured; Chemokine CCL2; Dose-Response Relationship, Drug; Drug Delivery Systems; Immunotherapy; Indazoles; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Propionates; RAW 264.7 Cells | 2020 |
Prevention of Obesity Related Diseases through Laminarin-induced targeted delivery of Bindarit.
Topics: Adipose Tissue; Animals; Atherosclerosis; Computer Simulation; Diet, High-Fat; Fatty Liver; Glucans; Humans; Indazoles; Inflammation; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Monocytes; Nanoparticles; Obesity; Plaque, Atherosclerotic; Propionates | 2020 |